Navigation Links
New Jersey Hospital Association Prescription Program Outpaces Industry
Date:2/18/2008

PRINCETON, N.J., Feb. 18 /PRNewswire/ -- ARMSRx (Administered Risk Management Services Rx), Pharmacy Benefit Consultants, the health care industry's leader in transparent pharmacy benefits negotiation and assessment, has performed an annual audit and review for The New Jersey Hospital Association's (NJHA) Employee Benefit Prescription Program. ARMSRx represents the association, its member hospitals, third party administrators and employers participating in its PBM program.

The Audit findings indicate that the New Jersey Hospital Association's 2007 Per Member per Month cost increased by only 2.6% over the entire book of business. The major PBMs in the marketplace are seeing increases of 6% plus. Even though the majority of NJHA employers do not employ mandatory generic programs, the overall generic fill rate was up from 51.1% to 55.7%. The most impressive discovery is that over 25% of the active 2006 & 2007 clients have negative trends!

Jennifer Kingsley Wilson, CEO of ARMSRx, values NJHA's aggressive stance on transparency and reducing the Rx costs through creative contractual structuring and not necessarily increasing the employee cost share outlandishly driven by consumerism. "Our clients are pleased to find ways to reduce costs without having to upset the employees that need the Rx benefit the most with the ever so popular cost shift."

The NJHA program offers leverage, aggressive pricing, stringent performance guarantees and formulary alignment that far exceed programs currently offered in the marketplace. Originally developed for the NJHA member hospitals, the program has evolved to include non-hospital employers due to broker and consultant demand to place other clients on this well received "New Generation of Pharmacy Benefit" program.

William Kennedy, Sr. Vice President, NJHA Corporate Services states, "Our members appreciate that NJHA has been able to leverage their purchasing arrangements to reduce costs without compromisi
'/>"/>

SOURCE ARMSRx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Brandywine Senior Living Completes Acquisition of Four Assisted Living Communities in New Jersey
2. United States Joins False Claims Act Cases Against Three New Jersey Hospitals
3. QMed, Inc. Announces the Termination of Its New Jersey Special Needs Plan
4. AHF Says Op-Out Clause is Crucial to New Jersey Law Requiring HIV Testing of Pregnant Women
5. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Northern New Jersey Elementary and Middle Schools
6. New Jersey Hospitals Post Razor Thin 0.6 Percent Operating Margin for 2006, Down 1 Percent from 2005
7. Keisha Orr of Edgewater Park, New Jersey is Named Philadelphias 2007 Local Loser
8. Distinctive Art Auction Supports American Red Cross of Central New Jersey
9. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
10. FDA Inspects Hoviones Technology Transfer Center in New Jersey
11. New Jersey Entrepreneur Turns a Page for Four National Charities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...: The National AIDS Control Organization (NACO) ha...ng 54, to provide free anti-retroviral treatment (...h 9 more centers on the anvil. These centers will...0 patients, who will avail the services of exclusi...
...f its continued efforts to give back to the cancer...al scientific meetings//, the Fairfax, Virginia-ba... Oncology (ASTRO) is partnering with Cancer Hope N...p. The Cancer Hope Network is a non-profit organiz...
...tereotypical self-image as the “strong, silent typ...why older men //are less likely than women to be r...t for depression, and to recognize and express sym...recruiters interviewed for a new study from the UC...
...rs at the George Institute for International Healt... disease is the number one killer in rural India. ...urvey in Andhra Pradesh. The findings of the surve...pidemiology this week. The report said India needs...
Other Medicine News:Health News:Cancer Hope Network, ASTRO Partner to Raise Awareness of Cancer Survivorship 2Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 2Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 3Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 4Health News:Chronic Diseases Rampant In Rural India 2
(Date:8/26/2008)...wire/ -- The Oregon Tourism Commission,launched it...aining Program,(Q Care) this week on http://www.O...gram created to support the tourism and,hospitalit... emphasizing,the importance of quality customer se...s and resources to better serve Oregon,s visitors....
(Date:8/26/2008)...swire/ -- Semafore Pharmaceuticals Inc.,announced ...ss on Targeted,Therapies in Cancer in Washington, ...f vascular-targeted PI3 kinase (PI3K) inhibitor SF...I3K is part of a very powerful pathway, the PI3/AK...r role in cancer. Studies have shown that by,inhib...
(Date:8/26/2008)...n drive safely six weeks following surgical,treatm...re/ -- Six weeks following,bunion surgery, most pa...to,get back behind the wheel of a car again. A stu...al of Bone and Joint Surgery ( http://www.jbjs.org...in patients who underwent a,first metatarsal osteo...
(Date:8/26/2008)...wswire/ -- Cambridge Research &,Instrumentation, I... EX In,Vivo Imaging System. The new system incorpo...ecomes the entry-level instrument of choice for in...newscom.com/cgi-bin/prnh/20080826/NETU054 ), FLE...of CRi,s unique,solid-state tunable optics that fo...
Breaking Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Braking After Bunion Surgery 2Braking After Bunion Surgery 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2How cancer spreads by aggregating platelets 192 1How cancer spreads by aggregating platelets 192 2How cancer spreads by aggregating platelets 192 3New Treatment Explored for Cluster Headaches 246 1New Treatment Explored for Cluster Headaches 246 2New Treatment Explored for Cluster Headaches 246 3Wolves find happy hunting grounds in Yellowstone National Park 189 1Wolves find happy hunting grounds in Yellowstone National Park 189 2Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 1Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 2Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 3Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 167 4
...mic Analyses of School and Daycare Study Outcomes ...e Cost Savings for,Community at Large, TORONTO..., Inc.,announced today research results showing ...Live, Intranasal) in daycare and school,settings... Economic,analyses applied to outcomes observed ...
...entific Presentation for Pristiq Occurs at the 55t...of Obstetricians and,Gynecologists, COLLEGEVILLE, ...Pharmaceuticals, a division of Wyeth , presented r...ristiq(TM) (desvenlafaxine) for,the treatment of m...and night sweats) associated with menopause. These...
Other Medicine Technology:Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 2Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 3Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 4Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 5Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 6Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 7Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 8Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6
Streck-Detergent III is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured for the Abbott CELL-DYN® 1400, 1600, 3500 and 3700. The shelf life
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer.
...us Retics is a 5-part differential control that co...r the Abbott CELL-DYN 3200, 3500, 3700 and 4000 in...ated red blood cells that can be analyzed and enum...tomated and manual reticulocyte values for all thr...
Para 12 Plus is a hematology control for the Abbott CELL-DYN 3000, 3200, and 3500/3700. Assay values are provided for the five-part white cell differential, as well as a three-part differential on th
Medicine Products: